Investors Research Corp Q2 2026 Portfolio Activity: Significant Buys & Sells Observed

As of June 30th, 2026, Investors Research Corp's portfolio has undergone several notable changes compared to the previous quarter. The total portfolio value stands at $553,347,929.

Among the most significant activities observed this quarter are substantial increases in holdings of certain exchange-traded funds (ETFs). SCHX, the Schwab Strategic Trust, saw a considerable boost with an increase of 32,896 shares and its value rising by 4.4%. Similarly, PGX experienced significant growth in both shares (+30,800) and percentage change (+5.33%). These movements suggest a strong interest from the investor in these specific ETFs.

In addition to increasing existing positions, Investors Research Corp also initiated new holdings during Q2 2026. Individual stocks like Hormel Foods Corporation (HRL) and McCormick & Company Inc. (MKC) were added to the portfolio, indicating a potential diversification strategy or interest in specific consumer defensive sectors.

Conversely, there was significant selling activity noted for several holdings. The investor completely exited positions in FDL and RWX (FDL) as well as SLB and CF (SLB, CF). These exits, particularly the near-total reduction of FDL (-52.69%) and RWX (-83.7%), represent major divestment actions.

Furthermore, substantial reductions were observed in other ETFs like PFXF (PFXF) with a decrease of 65.4% (change_percent_from_prior_period), and FTCS (FTCS) which saw its portfolio allocation drop by nearly 90%. These exits from established ETF positions are noteworthy for understanding the investor's current direction.

Overall, the quarter revealed a mix of strategic buying in specific sectors and significant selling or exiting of previous holdings. For more detailed information on Investors Research Corp's Q2 2026 portfolio changes, please refer to their latest filing data.